CRISPR Therapeutics Newsroom

CRISPR Therapeutics Analyst Ratings

BenzingaAug 12 09:03 ET

Truist Adjusts Price Target on CRISPR Therapeutics to $100 From $120, Maintains Buy Rating

MT NewswiresAug 12 06:13 ET

Crispr Therapeutics AG: Strategic Progress and Strong Financials Bolstering a Buy Rating

TipRanksAug 8 01:22 ET

Crispr Therapeutics AG Poised for Growth: Foroohar Maintains Buy Rating Amid Pipeline Progress and Strong Financials

TipRanksAug 7 01:28 ET

A Quick Look at Today's Ratings for CRISPR Therapeutics(CRSP.US), With a Forecast Between $30 to $105

Moomoo NewsAug 6 09:00 ET

Crispr Therapeutics AG (CRSP) Receives a Buy From Piper Sandler

TipRanksAug 6 07:30 ET

Crispr Therapeutics Price Target Cut to $94.00/Share From $112.00 by Chardan Capital

Dow JonesAug 6 06:56 ET

CRISPR Therapeutics Analyst Ratings

BenzingaAug 6 06:14 ET

Barclays Sticks to Its Hold Rating for Crispr Therapeutics AG (CRSP)

TipRanksAug 6 05:50 ET

Chardan Research Adjusts Price Target on CRISPR Therapeutics to $94 From $112, Maintains Buy Rating

MT NewswiresAug 6 05:44 ET

Buy Rating Affirmed for Crispr Therapeutics AG Amid Strong Commercial Prospects and Robust Pipeline Growth

TipRanksAug 6 04:47 ET

Rodman & Renshaw Initiates CRISPR Therapeutics at Buy With $90 Price Target

MT NewswiresAug 2 07:33 ET

TD Cowen Maintains CRISPR Therapeutics(CRSP.US) With Sell Rating, Maintains Target Price $30

Moomoo NewsJul 23 07:33 ET

CRISPR Therapeutics Analyst Ratings

BenzingaJun 27 05:35 ET

CRISPR Therapeutics Analyst Ratings

BenzingaJun 17 05:37 ET

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Crispr Therapeutics AG (CRSP) and Tango Therapeutics (TNGX)

TipRanksMay 23 19:05 ET

CRISPR Therapeutics Analyst Ratings

BenzingaMay 23 13:28 ET

Citigroup Maintains Buy on CRISPR Therapeutics, Lowers Price Target to $84

BenzingaMay 23 13:28 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Mersana Therapeutics (MRSN), Insulet (PODD) and Crispr Therapeutics AG (CRSP)

TipRanksMay 14 05:45 ET

Stifel Nicolaus Sticks to Their Hold Rating for Crispr Therapeutics AG (CRSP)

TipRanksMay 12 22:15 ET